Patents by Inventor Marco Cecchi

Marco Cecchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anavex2-73 for the treatment of alzheimer's disease
    Patent number: 11103478
    Abstract: Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: August 31, 2021
    Assignee: ANAVEX LIFE SCIENCES CORP.
    Inventor: Marco Cecchi
  • Anavex2-73 for the Treatment of Alzheimer's Disease
    Publication number: 20200022943
    Abstract: Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
    Type: Application
    Filed: September 27, 2019
    Publication date: January 23, 2020
    Applicant: ANAVEX LIFE SCIENCES CORP.
    Inventor: Marco Cecchi
  • Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease
    Patent number: 10426754
    Abstract: Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: October 1, 2019
    Assignee: ANAVEX LIFE SCIENCES CORP.
    Inventor: Marco Cecchi
  • Anavex2-73 for the Treatment of Alzheimer's Disease
    Publication number: 20180360796
    Abstract: Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
    Type: Application
    Filed: June 14, 2017
    Publication date: December 20, 2018
    Inventor: Marco Cecchi